Previous Article | Next Article 
Clinical and Diagnostic Laboratory Immunology, January 2001, p. 52-57, Vol. 8, No. 1
1071-412X/01/$04.00+0 DOI: 10.1128/CDLI.8.1.52-57.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Development of an Enzyme-Linked Immunosorbent Assay
for Serotyping Ureaplasma urealyticum Strains Using
Monoclonal Antibodies
Fedoua
Echahidi,
Gaëtan
Muyldermans,
Sabine
Lauwers, and
Anne
Naessens*
Department of Microbiology, Academisch
Ziekenhuis, Vrije Universiteit Brussel, Brussels, Belgium
Received 8 May 2000/Returned for modification 15 August
2000/Accepted 20 September 2000
 |
ABSTRACT |
Ureaplasma urealyticum comprises 14 serotypes. The existing serotyping methods all use polyclonal
antibodies. These methods are time-consuming and labor-intensive, and
they cannot always be performed on primary isolates; in addition, the
results are difficult to interpret. We developed a new enzyme-linked
immunosorbent assay (ELISA) method using serotype-specific monoclonal
antibodies (MAbs) to enable the serotyping of U. urealyticum isolates from primary broth cultures.
Each of the 14 serotype reference strains was tested against 14 selected MAbs. Homologous reactions were very strong, while
heterologous reactions were negligible. Three cross-reactions were
observed: MAb 5 cross-reacted with serotype 2, MAb 14 cross-reacted
with serotype 3, and MAb 8 cross-reacted with serotype 13. Despite the
cross-reactions observed, all the serotype reference strains of
U. urealyticum could be identified and
differentiated using a combination of MAbs. Reproducibility was
analyzed with a fractionated antigenic preparation and with several
freshly prepared antigens of the same strain. No significant interrun
variation was found with the fractionated antigen, but significant
variations in optical density (OD) values were found when freshly
prepared antigens were tested. However, the variation in OD values did
not influence the overall interpretation of the ELISA: reactions with
homologous MAbs were always prominent compared to those of the negative
controls. This newly developed ELISA using MAbs seems promising for
serotyping of U. urealyticum clinical isolates.
 |
INTRODUCTION |
Ureaplasma
urealyticum is a common inhabitant of the human lower
genital tract. In some cases, a causal relationship between U. urealyticum and unfavorable fetal outcome was
established 3, 8, 9, 14, 29, 31. Despite these case
reports, its pathogenic role in diseases of reproduction remains
controversial. Because of the difficulties in establishing the
pathogenic role of U. urealyticum in diseases of
the reproductive tract, it has been postulated that only certain
subgroups of U. urealyticum are associated with
disease. There are 14 serotypes of U. urealyticum which can be classified into two biovars
according to differences in phenotypic and genotypic characteristics
6, 12, 20, 21, 23, 28. Serotyping of U. urealyticum strains is helpful for studying a possible
link between serotypes and disease. Until now, advances made in this
field were limited, since only a few serotyping studies have been
performed. Moreover, these studies have shown conflicting results
10, 15, 17, 24, 26. The difficulty in interpretation of
results for the available serotyping methods 15, 27 may be
one explanation for these conflicting results. For serotyping of
clinical strains, very often subculturing is a prerequisite. If one
deals with mixed serotypes, subculturing may favor one of the
serotypes, and this can influence the serotyping results. There is
therefore a need for an easier and more reliable test for the
serotyping of strains isolated from primary cultures which can detect
mixed serotypes. For this purpose, we developed an enzyme-linked
immunosorbent assay (ELISA) that could serve as a good alternative for
the existing serotyping methods.
 |
MATERIALS AND METHODS |
Type strains.
Reference strains of U. urealyticum serotypes 1 to 10 were supplied by E. A. Freund (Institute of Medical Microbiology, University of Aarhus,
Aarhus, Denmark), and those of serotypes 11 to 14 were supplied by
J. A. Robertson (Department of Medical Microbiology and Infectious
Diseases, University of Alberta, Edmonton, Canada).
Antigen preparation.
Antigens used in the ELISA were
prepared by growing U. urealyticum reference
strains in 10 ml of bromothymol blue broth 22. The cells
were harvested by centrifugation at 25,000 × g for 30 min at 4°C. The pellet was then washed three times with
phosphate-buffered saline (PBS), and the final pellet was resuspended
in 100 µl of PBS and stored at
80°C until use.
MAb selection and purification.
Fourteen monoclonal
antibodies (MAbs) able to differentiate the 14 serotypes 7
were selected for use in the ELISA. For serotypes 1, 2, 3, 4, 6, 7, 8, 9, 10, 11, and 12, serotype-specific MAbs were used. For serotyping of
U. urealyticum serotypes 5, 13, and 14, we used
cross-reactive MAbs as determined by indirect immunofluorescence assay
(IFA). The MAb for serotype 5 cross-reacts with serotype 2, the MAb for
serotype 14 cross-reacts with serotype 3, and the MAb for serotype 13 cross-reacts with serotype 8.
The MAbs of the immunoglobulin G isotype were purified using the
TrapGII kit (Amersham Pharmacia Biotechnologies, Uppsala, Sweden). The
MAbs of the immunoglobulin M isotype were purified with the E-Z-SEP kit
(Amersham Pharmacia Biotechnologies). The concentrations of the
purified MAbs were determined by measuring the absorbancy at 280 nm.
ELISA method.
For coating of microtiter plates, 100 µl of
the antigenic preparation diluted in ethanol was added to each well and
incubated at 37°C until complete evaporation of the ethanol. The
wells were saturated with bovine serum albumin (3% [wt/vol]) in PBS
and then washed twice. Washing was performed with PBS containing 0.1%
Tween 20. One hundred microliters of MAbs diluted in PBS was added to the wells and incubated for 1 h at 37°C. After a wash, 100 µl of horseradish peroxidase-labeled polyclonal anti-mouse immunoglobulins (called conjugate below) diluted in PBS containing 0.05% Tween 20 was
added to the wells and the mixtures were incubated for 1 h at
37°C. After a wash, the peroxidase substrate
(o-phenylenediamine) was added to the wells and the mixtures
were incubated for 30 min in the dark at room temperature. The
substrate reaction was stopped by adding H2SO4
(4 N), and the optical density (OD) was measured at 492 nm.
Method optimization.
The reference strains of serotypes 4 and 9 were used to study the optimal conditions for the test procedure.
After optimization, each antibody was tested against the 14 different
U. urealyticum serotypes. Negative controls were
obtained by testing the conjugate without adding MAbs. The blank wells
received ELISA reagents but no antigens and no MAbs.
 |
RESULTS |
Method optimization. (i) Coating conditions.
The coating was
optimized by testing the following three coating conditions: (i)
Maxisorp Nunc plate with the coating buffer Tris-buffered saline, pH
8.6; (ii) Maxisorp Nunc plates with the coating buffer
carbonate-bicarbonate, pH 9.63; and (iii) Polysorp Nunc plates with
ethanol as the coating buffer. The conditions were tested with
whole-cell antigens as well as with sonicated antigens. The highest OD
values, corresponding to the reaction of MAbs with homologous antigens,
were obtained using the Polysorp Nunc plates with ethanol as the
coating buffer (data not shown). The use of sonicated antigens did not
increase the OD values compared to the use of whole-cell antigens. For
further experiments we used whole-cell antigens diluted in ethanol to
coat Polysorp Nunc plates.
(ii) Antigen and antibody concentrations.
Results of
determination of the optimal concentrations of antigen and
antibody are shown in Fig. 1. MAb
concentrations ranging between 2.5 and 5 µg/ml and antigen
dilutions ranging between 1/40 and 1/80 yielded adequate OD values with
minimal background.

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 1.
Absorbancy curves for MAb 4 at different concentrations
tested with U. urealyticum serotype 4 antigen at
different dilutions.
|
|
(iii) Reduction of nonspecific reactivity.
OD values for the
blank wells were very low, while those for negative controls ranged
between 0.25 and 0.3. In order to reduce the reactivity of the negative
control as well as the reactivity of antigens to heterologous MAbs, the
conjugate was preincubated with the culture medium of U. urealyticum. Preincubation for 1 h at room
temperature allowed significant reduction of negative-control and
heterologous-reaction values (Fig. 2).

View larger version (63K):
[in this window]
[in a new window]
|
FIG. 2.
Effect of preabsorption of the conjugate with the
culture medium of U. urealyticum on the negative
control and heterologous reaction mixture tested for serotype 9 antigen.
|
|
Reactivity of U. urealyticum reference
strains by ELISA.
Each of the 14 reference strains was tested
against all selected MAbs. Every serotype gave a strong reaction with
its homologous MAb (Fig.
3). Reactions with
heterologous MAbs were comparable to those of the negative controls,
except for serotypes 2, 3, and 8: serotype 2 also reacted with MAb 5 (Fig. 3d), serotype 3 reacted with MAb 14 (Fig. 3d), and serotype 8 reacted with MAb 13.




View larger version (68K):
[in this window]
[in a new window]
|
FIG. 3.
Histograms showing the reaction of selected MAbs with
antigens of the 14 serotypes of U. urealyticum
(columns 1 to 14). The height of each column corresponds to OD values
of homologous and heterologous reaction mixtures.
|
|
Reproducibility of the test.
The reproducibility of the test
was verified by analyzing a fractionated antigenic preparation in five
independent assays and by testing five different antigenic preparations
of serotype 4 in five independent assays. No significant interrun
variation of a fractionated antigenic preparation was found (Table
1). However, interrun variations of
different antigenic preparations of serotype 4 were considerable (Table
2). Nevertheless, reactions with
homologous MAbs were always very prominent compared to those of
negative controls.
 |
DISCUSSION |
U. urealyticum comprises 14 serotypes
currently distributed between two biovars: the Parvo biovar (serotypes
1, 3, 6, and 14) and the T960 biovar (serotypes 2, 5, and 7 through
13). Strong evidence has suggested recently that these two biovars
should be classified as distinct species: Ureaplasma parvum
and U. urealyticum 11. Different
methods for serotyping, all using polyclonal antibodies (PAbs), have
been described previously 1, 2, 13, 18, 19, 25, 30. Until
now, IFA has been the test most commonly performed. Serotyping of
U. urealyticum with PAbs in IFA is subject to
many problems that make it difficult to interpret the serotyping results. Polyreactivity of some clinical strains is the major problem
observed. Another problem is the lack of reproducibility: repeated
testing of some strains with PAbs was sometimes associated with the
disappearance of a positive reaction when more than one specificity was
found or by a shift from a negative to a positive reaction
15. The comparison of serotyping results obtained by two
laboratories using nonidentical immunoreagents showed discrepancies and
clearly demonstrated the difficulty in the interpretation of serotyping
results 16. To overcome some of the problems with serotyping U. urealyticum using PAbs, we
produced MAbs to U. urealyticum serotypes and
tested them by IFA with selected clinical isolates 4, 5, 7,
16. Serotyping of clinical isolates with MAbs seems better than
serotyping with PAbs, since repeated tests were always reproducible and
polyreactivity was not observed within clinical isolates. However, IFA
is difficult to perform. Indeed, IFA requires well-grown colonies on
agar plates. This is time-consuming, and once enough colonies have
grown, the plates cannot be kept for a long time before being
tested. In addition, the need for microscopic observation
makes the technique very fastidious when large numbers of strains are
to be serotyped. In this study, we developed an indirect ELISA method
to serotype U. urealyticum strains using
serotype-specific MAbs. Two different microtiter plates were tested:
the Maxisorp Nunc plate and the Polysorp Nunc plate. The first plate is
suitable for coating hydrophilic proteins, whereas the latter plate is
suitable for coating hydrophobic as well as amphiphilic proteins.
Significantly higher OD values were obtained when using the Polysorp
plate, suggesting that serotype-specific antigens of U. urealyticum are probably amphiphilic and not hydrophilic.
With the new ELISA method, high OD values were obtained for the
reference strains when tested against their homologous MAbs. Significant cross-reactivities were observed for serotypes 2, 3, and
13. Since identical cross-reactivities have been observed by IFA
7, it is likely that the cross-reactivities observed in
the ELISA are due to the selected MAbs rather than to the methodology of the ELISA. Despite the cross-reactivities observed, all the serotypes of U. urealyticum could be identified
and differentiated by the ELISA using a combination of the MAbs described.
Since reproducibility is very important in serotyping assays of
U. urealyticum, we tested the reproducibility
with a single fractioned antigenic preparation as well as with several
newly prepared antigenic preparations. For the new ELISA, no
significant variation was found between repeated tests of a
fractionated antigenic preparation. However, for different antigenic
preparations of the same strain, variation between repeated tests was
important. This variation is probably due to the nonstandardized
preparation of the antigens. Strains can be harvested at different
phases of growth, leading to different antigenic concentrations. This could be overcome by introducing a supplementary step for exact determination of the concentration of each antigenic preparation and
adjustment of the test to a standardized concentration. However, adjustment to a standardized concentration is very difficult with U. urealyticum. Concentration adjustment by
measuring the concentration of the antigen in the pellet can lead to a
false estimate, since the pellet issued from culture centrifugation
contains a lot of medium components. Concentration adjustment before
harvesting cannot be performed by measuring the turbidity, since
U. urealyticum does not produce visible growth
in broth medium. The only way that one could standardize the antigenic
concentration is by measuring the CFU of U. urealyticum from the broth culture. This method, however, is very laborious and, if introduced in the serotyping procedure, would undo the handy aspect of the present serotyping method. Since the fluctuation in OD values had no influence on the
final results of the ELISA reactivity
reactions with homologous MAbs
were always very prominent compared to those of negative controls
we
decided to omit this supplementary standardization. Nevertheless, the
use of nonstandardized antigen should be taken into account when
interpreting the ELISA results. For example, a minimal cutoff value is
needed. We arbitrarily determined a cutoff OD value of 0.4 (after
negative control subtraction). A strain with at least one positive
reaction can be considered serotyped. However, if no positive reactions
are observed with the 14 MAbs, the whole serotyping procedure has to be
repeated with a more concentrated antigenic preparation. Indeed, a
negative reaction can occur in the case of a nontypeable strain or in a
serotyping procedure using insufficient antigenic preparation. Simply
repeating the test with a higher antigenic concentration enables us to
discriminate between nontypeable strains and false-negative reactions.
The difficult growth characteristics of U. urealyticum are the reason for the inconsistent
concentrations. These characteristics interfere with the antigenic
concentration not only with the ELISA method but also with the other
serotyping methods described before now. For IFA, serotyping can be
performed only when enough growth is obtained, often after subculturing.
For the new ELISA method, antigens can be prepared from primary broth
cultures. Serotyping before subculture constitutes an important
advantage, because selection can occur in case of mixed serotypes.
Antigens can be stored for a long time before performing the test,
while for IFA the agar plates can be kept only for a short time. The
ELISA offers the possibility of automation, and unlike in the IFA,
where microscopic observation is necessary, reading of the final
reaction in the ELISA is performed by a spectrophotometer. These
characteristics make the test easy to perform and applicable for
serotyping large numbers of strains for epidemiological purposes.
Since promising results were obtained with the new indirect ELISA using
the reference strains of U. urealyticum, the
method will be used to serotype a large number of clinical isolates
in order to evaluate the test under clinical conditions in comparison with the existing IFA method.
 |
ACKNOWLEDGMENT |
This work was supported by a grant from the Steunfonds
Marguerite-Marie Delacroix.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Microbiology, Academisch Ziekenhuis, Vrije Universiteit Brussel,
Laarbeeklaan 101, 1090-Brussels, Belgium. Phone: 32-2-477.50.00. Fax:
32-2-477.50.15. E-mail: Anne.Naessens{at}az.vub.ac.be.
 |
REFERENCES |
| 1.
|
Black, F. T.
1970.
Serological methods for classification of human T-mycoplasmas, p. 407-411.
In
Fifth International Congress on Infectious Diseases, vol. 1. Weiner Medizinische Akademie, Vienna, Austria.
|
| 2.
|
Black, F. T.
1973.
Modifications of the growth inhibition test and its application to human T-mycoplasmas.
Appl. Microbiol.
25:528-533[Medline].
|
| 3.
|
Cassell, G. H.,
K. B. Waites,
H. L. Watson,
D. T. Crouse, and R. Harasawa.
1993.
Ureaplasma urealyticum intrauterine infection: role in prematurity and disease in newborns.
Clin. Microbiol. Rev.
6:69-87[Abstract/Free Full Text].
|
| 4.
|
Cheng, X.,
A. Naessens, and S. Lauwers.
1993.
Identification and characterization of serotype 4-specific antigens of Ureaplasma urealyticum by use of monoclonal antibodies.
Infect. Immun.
61:2253-2256[Abstract/Free Full Text].
|
| 5.
|
Cheng, X.,
A. Naessens, and S. Lauwers.
1994.
Identification of serotype 1-, 3-, and 6-specific antigens of Ureaplasma urealyticum by using monoclonal antibodies.
J. Clin. Microbiol.
32:1060-1062[Abstract/Free Full Text].
|
| 6.
|
Christiansen, C.,
F. T. Black, and E. A. Freundt.
1981.
Hybridization experiments with deoxyribonucleic acid from Ureaplasma urealyticum serovars I to VIII.
Int. J. Syst. Bacteriol.
31:259-262[Abstract/Free Full Text].
|
| 7.
|
Echahidi, F.,
G. Muyldermans,
S. Lauwers, and A. Naessens.
2000.
Development of monoclonal antibodies against Ureaplasma urealyticum serotypes and their use for serotyping clinical isolates.
Clin. Diagn. Lab. Immunol.
7:563-567[Abstract/Free Full Text].
|
| 8.
|
Foulon, W.,
A. Naessens,
M. Dewaele,
S. Lauwers, and J. J. Amy.
1986.
Chronic Ureaplasma urealyticum amnionitis associated with abruptio placentae.
Obstet. Gynecol.
68:280-282[Medline].
|
| 9.
|
Foulon, W.,
D. Van Liedekerke,
C. Demanet,
L. Decatte,
M. Dewaele, and A. Naessens.
1995.
Markers of infection and their relationship to preterm delivery.
Am. J. Perinatol.
12:208-311[Medline].
|
| 10.
|
Hewish, M. J.,
D. F. Birch, and K. F. Fairley.
1986.
Ureaplasma urealyticum serotypes in urinary tract disease.
J. Clin. Microbiol.
23:149-154[Abstract/Free Full Text].
|
| 11.
|
Kong, F.,
G. James,
Z. Ma,
S. Gordon,
B. Wang, and G. L. Gilbert.
1999.
Phylogenetic analysis of Ureaplasma urealyticum support for the establishment of a new species, Ureaplasma parvum.
Int. J. Syst. Bacteriol.
49:1879-1889[Abstract/Free Full Text].
|
| 12.
|
Mouches, C.,
D. Taylor-Robinson,
L. Stipkovits, and J. M. Bove.
1981.
Comparison of human and animal Ureaplasmas by one- and two-dimensional protein analysis on polyacrylamide slab gel.
Ann. Microbiol. (Paris)
132B:171-196[Medline].
|
| 13.
|
Naessens, A., and S. Lauwers.
1987.
Modified indirect immunofluorescence test for serotyping large numbers of Ureaplasma urealyticum clinical isolates.
J. Clin. Microbiol.
25:191-192[Abstract/Free Full Text].
|
| 14.
|
Naessens, A.,
W. Foulon,
H. Cammu,
A. Goossens, and S. Lauwers.
1987.
Epidemiology and pathogenesis of Ureaplasma urealyticum in spontaneous abortion and early preterm labor.
Acta Obstet. Gynecol. Scand.
66:513-516[Medline].
|
| 15.
|
Naessens, A.,
W. Foulon,
J. Breynaert, and S. Lauwers.
1988.
Serotypes of Ureaplasma urealyticum isolated from normal pregnant women and patients with pregnancy complications.
J. Clin. Microbiol.
26:319-322[Abstract/Free Full Text].
|
| 16.
|
Naessens, A.,
X. Cheng,
S. Lauwers, and J. A. Robertson.
1998.
Development of a monoclonal antibody to a Ureaplasma urealyticum serotype 9 antigen.
J. Clin. Microbiol.
36:1125-1127[Abstract/Free Full Text].
|
| 17.
|
Piot, P.
1976.
Distribution of eight serotypes of Ureaplasma urealyticum in cases of non-gonococcal urethritis and in healthy persons.
Br. J. Vener. Dis.
52:266-268[Medline].
|
| 18.
|
Purcell, R. H.,
D. Taylor-Robinson,
D. Wong, and R. M. Chanock.
1966.
Color test for the measurement of antibody to T-strain mycoplasmas.
J. Bacteriol.
92:6-12[Abstract/Free Full Text].
|
| 19.
|
Quinn, P. A.,
L. U. Arshoff, and H. C. S. Li.
1981.
Serotyping of Ureaplasma urealyticum by immunoperoxidase assay.
J. Clin. Microbiol.
13:670-676[Abstract/Free Full Text].
|
| 20.
|
Razin, S.,
R. Harasawa, and M. F. Barile.
1983.
Cleavage patterns of the mycoplasma chromosome, obtained by using restriction endonucleases as indicators of genetic relatedness among strains.
Int. J. Syst. Bacteriol.
33:201-206[Abstract/Free Full Text].
|
| 21.
|
Razin, S., and D. Yogev.
1986.
Genetic relatedness among Ureaplasma urealyticum serotypes (serovars).
Pediatr. Infect. Dis.
5(Suppl 6):S300-S304[Medline].
|
| 22.
|
Robertson, J. A.
1978.
Bromothymol blue broth: improved medium for detection of Ureaplasma urealyticum (T-strain mycoplasma).
J. Clin. Microbiol.
7:127-132[Abstract/Free Full Text].
|
| 23.
|
Robertson, J. A., and M. H. Chen.
1984.
Effects of manganese on the growth and morphology of Ureaplasma urealyticum.
J. Clin. Microbiol.
19:857-864[Abstract/Free Full Text].
|
| 24.
|
Robertson, J. A.,
L. H. Honore, and G. W. Stemke.
1986.
Serotypes of Ureaplasma urealyticum in spontaneous abortion.
Pediatr. Infect. Dis.
5(Suppl. 6):S270-S272[Medline].
|
| 25.
|
Rosendal, S., and F. T. Black.
1972.
Direct and indirect immunofluorescence of unfixed and fixed Mycoplasma colonies.
Acta Pathol. Microbiol. Scand.
80:615.
|
| 26.
|
Shepard, M. C., and C. D. Lunceford.
1978.
Serological typing of Ureaplasma urealyticum isolates from urethritis patients by an agar growth inhibition method.
J. Clin. Microbiol.
8:566-574[Abstract/Free Full Text].
|
| 27.
|
Stemke, G. W., and J. A. Robertson.
1985.
Problems associated with serotyping strains of Ureaplasma urealyticum.
Diagn. Microbiol. Infect. Dis.
3:311-320[CrossRef][Medline].
|
| 28.
|
Swenson, C. E.,
J. Van Hamont, and B. S. Dunbar.
1983.
Specific protein differences among strains of Ureaplasma urealyticum as determined by two-dimensional gel electrophoresis and a sensitive silver stain.
Int. J. Syst. Bacteriol.
33:417-421.
|
| 29.
|
Taylor-Robinson, D.,
G. W. Csonka, and M. J. Prentice.
1977.
Human intra-urethral inoculation of ureaplasmas.
Q. J. Med.
46:309-326[Abstract/Free Full Text].
|
| 30.
|
Turunen, H.,
P. Leinikki, and E. Jansson.
1982.
Serological characterisation of Ureaplasma urealyticum strains by enzyme-linked immunosorbent assay (ELISA).
J. Clin. Pathol.
35:439-443[Abstract/Free Full Text].
|
| 31.
|
Waites, K. B.,
D. T. Crouse,
J. B. Philips,
K. C. Canupp, and G. H. Cassell.
1989.
Ureaplasmal pneumonia and sepsis associated with persistent pulmonary hypertension of the newborn.
Pediatrics
83:79-85[Abstract/Free Full Text].
|
Clinical and Diagnostic Laboratory Immunology, January 2001, p. 52-57, Vol. 8, No. 1
1071-412X/01/$04.00+0 DOI: 10.1128/CDLI.8.1.52-57.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.